Cargando…

Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report

INTRODUCTION: Rare FGF23-producing mesenchymal tumors lead to paraneoplastic tumor-induced osteomalacia (TIO) presenting with phosphate wasting, hypophosphatemia, chronic hypomineralization of the bone, fragility fractures and muscle weakness. Diagnosis of TIO requires exclusion of other etiologies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryhänen, Eeva M., Schalin-Jäntti, Camilla, Matikainen, Niina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8209372/ https://www.ncbi.nlm.nih.gov/pubmed/34149623 http://dx.doi.org/10.3389/fendo.2021.686135

Ejemplares similares

Cushing's syndrome, pheochromocytoma, or both?
por: Kullamaa, Liisa, et al.
Publicado: (2023)

Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms
por: Storvall, Sara, et al.
Publicado: (2023)

Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument
por: Ryhänen, Eeva M, et al.
Publicado: (2015)

Bone Volumetric Density, Microarchitecture, and Estimated Bone Strength in Tumor-Induced Rickets/Osteomalacia Versus X-linked Hypophosphatemia in Chinese Adolescents
por: Jiajue, Ruizhi, et al.
Publicado: (2022)

Recurrent Metastasized Parathyroid Carcinoma—Long‐Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide
por: Storvall, Sara, et al.
Publicado: (2018)

Somatostatin receptor expression in parathyroid neoplasms
por: Storvall, Sara, et al.
Publicado: (2019)

(99m)Technetium Sestamibi-(123)Iodine Scintigraphy Is More Accurate Than (99m)Technetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism
por: Ryhänen, Eeva M., et al.
Publicado: (2015)

Adrenal androgens versus cortisol for primary aldosteronism subtype determination in adrenal venous sampling
por: Viukari, Marianna, et al.
Publicado: (2022)

CDC73 Intragenic Deletion in Familial Primary Hyperparathyroidism Associated With Parathyroid Carcinoma
por: Korpi-Hyövälti, Eeva, et al.
Publicado: (2014)

Hypophosphatemia and FGF23 tumor-induced osteomalacia in two cases of metastatic breast cancer
por: Abramson, Matthew, et al.
Publicado: (2021)

Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia
por: Högler, Wolfgang, et al.
Publicado: (2019)

MGMT Promoter Methylation and Parathyroid Carcinoma
por: Storvall, Sara, et al.
Publicado: (2019)

Thymic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1
por: Yliaska, Iina, et al.
Publicado: (2022)

Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours
por: Kostiainen, Iiro, et al.
Publicado: (2022)

SUN-364 Enthesophytes Are a Common Feature of FGF23-Mediated Hypophosphatemia Due to Tumor-Induced Osteomalacia
por: Gafni, Rachel Ilana, et al.
Publicado: (2020)

Editorial: Rickets and osteomalacia, from genes to nutrition
por: Doulgeraki, Artemis, et al.
Publicado: (2023)

Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

Cortisol and Phosphate Homeostasis: Cushing’s Syndrome Is Associated With Reversible Hypophosphatemia
por: Bosman, Ariadne, et al.
Publicado: (2021)

Sphenoid sinus is a rare site for tumor-induced osteomalacia: A case report and literature review
por: Wang, Fen, et al.
Publicado: (2023)

Rare Diseases That Impersonate One Another: X‐Linked Hypophosphatemia and Tumor‐Induced Osteomalacia, a Retrospective Analysis of Discriminating Features
por: DeCorte, Joseph, et al.
Publicado: (2022)

Corrigendum: Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium
por: Laurent, Michaël R., et al.
Publicado: (2021)

Clinical and genetic characteristics of 29 Chinese patients with X-linked hypophosphatemia
por: Xu, Tian, et al.
Publicado: (2022)

Dental health of pediatric patients with X-linked hypophosphatemia (XLH) after three years of burosumab therapy
por: Brener, Rafi, et al.
Publicado: (2022)

Lower Limb Deformity and Gait Deviations Among Adolescents and Adults With X-Linked Hypophosphatemia
por: Mindler, Gabriel T., et al.
Publicado: (2021)

Elevated morbidity and mortality in patients with chronic idiopathic hypophosphatemia: a nationwide cohort study
por: Kim, Kyoung Jin, et al.
Publicado: (2023)

Treatment of hypophosphatemia in the intensive care unit: a review
por: Geerse, Daniël A, et al.
Publicado: (2010)

A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion
por: Schalin-Jäntti, Camilla, et al.
Publicado: (2015)

Hypophosphatemic Osteomalacia in a Young Adult
por: Paramba, Firjeeth, et al.
Publicado: (2021)

Tumor-induced hypophosphatemia
por: Mulani, M., et al.
Publicado: (2017)

Clinical Evidence for the Benefits of Burosumab Therapy for X-Linked Hypophosphatemia (XLH) and Other Conditions in Adults and Children
por: Schindeler, Aaron, et al.
Publicado: (2020)

Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries
por: Mughal, M. Zulf, et al.
Publicado: (2023)

Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms
por: Becker, Anna, et al.
Publicado: (2021)

A Case Report of Hypophosphatemia Leading to the Diagnosis of Mesothelioma
por: Goh, Zi W, et al.
Publicado: (2022)

The Impact of Moderate Hypophosphatemia on the Clinical Management of Primary Hyperparathyroidism
por: Güneş, Elif, et al.
Publicado: (2023)

Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X‐Linked Hypophosphatemia: A Phase 3, Single‐Arm, International Trial
por: Insogna, Karl L, et al.
Publicado: (2019)

Tumor-induced osteomalacia
por: Florenzano, Pablo, et al.
Publicado: (2017)

Tumor-induced osteomalacia
por: Yin, Zinan, et al.
Publicado: (2018)

A Case Report: First Long-Term Treatment With Burosumab in a Patient With Cutaneous-Skeletal Hypophosphatemia Syndrome
por: Merz, Lea Maria, et al.
Publicado: (2022)

Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia
por: Colazo, Juan M., et al.
Publicado: (2020)

Tumor-Induced Osteomalacia With Normal Fibroblast Growth Factor-23 (FGF23) and Idiopathic Hypercalciuria
por: Velazquez-Navarro, Jassel A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kp6jonsklh9f02fu5ki3jsrln4